Full Paper
(41), 85 (38), 83 (49), 77 (30), 71 (63), 70 (38), 69 (83), 57 (100), 56
(31), 55 (82); HRMS (TOF): m/z calcd for C13H1679BrO4 [M+H]+,
C13H1681BrO4 [M+H]+: 315.0226, 317.0206; found: 315.0222,
317.0197.
78.9, 98.0 (minor), 98.3, 116.8, 124.9 (minor), 126.0, 127.1 (minor),
128.0, 128.4 (minor), 128.5, 136.9, 141.5, 142.6 (minor), 153.8,
155.0 ppm; LRMS (EI): m/z (%): 360 (54) [C19H1981BrO2]+, 358 (57)
[C19H1979BrO2]+, 256 (87), 254 (92), 175 (100), 115 (53), 104 (44), 103
(37), 91 (55), 78 (25), 77 (28); HRMS (TOF): m/z calcd for
C19H2079BrO2 [M+H]+, C19H2081BrO2 [M+H]+: 359.0641, 361.0621;
found: 359.0636, 361.0623.
Compound 23
Following the general procedure for the borohydride reduction/
acetylation (with the reduction requiring 18 h), indanone 20
(0.300 g, 0.958 mmol) was converted into the corresponding indan-
yl acetate 23 as a white solid (0.277 g, 0.778 mmol, 81% over two
steps).
Compound 28
Following the general procedure for the [PtCl4]-mediated genera-
tion of the o-QM/HDA reaction, indanyl acetate 23 (0.020 g,
0.056 mmol) reacted with cinnamate 27 (0.023 g, 0.112 mmol) for
18 h to give 28 as a white solid (0.020 g, 0.045 mmol, 80%). M.p.
Note: During purification by chromatography on silica gel with
20% EtOAc/hexanes, it is critical that Et3N (1% v/v) is included to
prevent decomposition of the product. It is also important to
ensure complete removal of Et3N in vacuo because its presence,
even in trace amounts, interferes with the subsequent [PtCl4]-medi-
ated reaction. M.p. (EtOAc/hexanes) 102.6–103.88C; 1H NMR
(300 MHz, CDCl3): d=2.03 (s, 3H), 2.06–2.17 (m, 1H), 2.37–2.53 (m,
1H), 2.90 (ddd, J=2.9, 9.0, 17.1 Hz, 1H), 3.01–3.16 (m, 1H), 3.46 (s,
3H), 3.89 (s, 3H), 5.18 (s, 2H), 6.39 (dd, J=1.7, 6.9 Hz, 1H),
6.60 ppm (s, 1H); 13C NMR (75 MHz, CDCl3): d=21.2, 31.9, 32.6,
56.0, 76.5, 94.3, 98.0, 100.7, 122.3, 148.5, 153.9, 157.9, 170.6 ppm;
IR (UATR): n˜max =2943, 1734, 1222, 1149 cmÀ1; LRMS (EI): m/z (%):
346 (4) [C14H1781BrO5]+, 344 (4) [C14H1779BrO5]+, 242 (97), 240 (100);
HRMS (TOF): m/z calcd for C14H1779BrNaO5 [M+Na]+, C14H1781BrNaO5
[M+Na]+: 367.0152, 369.0132; found: 367.0169, 369.0148.
1
(CH2Cl2/hexanes) 105.2–106.18C; H NMR (300 MHz, CDCl3): d=0.98
(t, J=7.1 Hz, 3H), 1.68–1.84 (m, 1H), 2.34–2.43 (m, 1H), 2.59 (appar-
ent t, J=10.4 Hz, 1H), 2.85–3.04 (m, 2H), 3.59 (dt, J=10.4, 6.4 Hz,
1H), 3.81 (s, 3H), 3.82 (s, 3H), 3.95 (q, J=7.1 Hz, 2H), 5.09 (d, J=
10.4 Hz, 1H), 6.30 (s, 1H), 6.95 (d, J=8.7 Hz, 2H), 7.31 ppm (d, J=
8.7 Hz, 2H); 13C NMR (75 MHz, CDCl3): d=14.0, 33.3, 43.2, 51.9,
55.3, 56.6, 60.7, 81.0, 97.2, 99.4, 113.9 (2C), 120.5, 128.9 (2C), 129.8,
145.6, 151.6, 156.5, 160.0, 172.1 ppm; IR (UATR): n˜max =2928, 1728,
1248, 1150 cmÀ1; LRMS (EI): m/z (%): 448 (11) [C22H2381BrO5]+, 446
(11) [C22H2379BrO5]+, 242 (20), 240 (20), 206 (80), 161 (63), 149 (100);
HRMS (TOF): m/z calcd for C22H2379BrNaO5 [M+Na]+, C22H2381BrNaO5
[M+Na]+: 469.0621, 471.0604; found: 469.0609, 471.0594.
Compound 30a
Compound 25
Following the general procedure for the [PtCl4]-mediated genera-
tion of o-QM/HDA reaction, indanyl acetate 23 (0.020 g,
0.056 mmol) reacted with cinnamate 29a (0.032 g, 0.112 mmol) for
18 h to give 30a as a white solid (0.020 g, 0.039 mmol, 69%). M.p.
Following the general procedure for the [PtCl4]-mediated genera-
tion of o-QM and HDA reaction, the indanyl acetate 23 (0.04 g,
0.11 mmol) was converted into the product 25 as a dark yellow
solid of a 6:1 mixture of inseparable diastereomers (0.021 g,
1
(CH2Cl2/hexanes) 109.4–111.88C; H NMR (300 MHz, CDCl3): d=0.95
1
(t, J=7.1 Hz, 3H), 1.66–1.85 (m, 1H), 2.31–2.45 (m, 1H), 2.58 (appar-
ent t, J=10.4 Hz, 1H), 2.82–3.05 (m, 2H), 3.58 (dt, J=10.4, 6.4 Hz,
1H), 3.82 (s, 3H), 3.94 (q, J=7.1 Hz, 2H), 5.075 (s, 2H), 5.083 (d, J=
10.4 Hz, 1H), 6.30 (s, 1H), 6.96 (d, J=8.7 Hz, 2H), 7.31 (d, J=8.7 Hz,
2H), 7.33–7.46 ppm (m, 5H); 13C NMR (75 MHz, CDCl3): d=14.0,
33.3, 33.9, 43.2, 51.9, 56.6, 60.7, 70.0, 81.0, 97.2, 99.4, 114.9 (2C),
120.5, 127.4 (2C), 128.0, 128.6 (2C), 128.9 (2C), 130.1, 136.8, 145.6,
151.5, 156.5, 159.1, 172.1 ppm; IR (UATR): n˜max =2936, 1728, 1589,
1148 cmÀ1; LRMS (EI): m/z (%): 524 (6) [C28H2781BrO5]+, 522 (6)
[C28H2779BrO5]+, 91 (100); HRMS (TOF): m/z calcd for C28H2879BrNaO5
[M+Na]+, C28H2881BrNaO5 [M+Na]+: 523.1115, 525.1099; found:
523.1114, 525.1110.
0.06 mmol, 53%). H NMR (300 MHz, CDCl3): d=1.59–1.67 (m, 2H),
1.74–1.86 (m, 2H, minor), 2.30–2.45 (m, 2H), 2.63–2.72 (m, 1H,
minor), 2.79–2.96 (m, 2H), 3.30–3.42 (m, 1H), 3.83 (s, 3H), 3.88 (s,
3H, minor), 5.10 (dd, J=2.1 Hz, 1H), 5.64 (d, J=3.0 Hz, 1H, minor),
6.31 (s, 1H), 6.40 (s, 1H, minor), 7.22–7.41 ppm (m, 5H); 13C NMR
(75 MHz, CDCl3): d=32.64 (minor), 33.61 (minor), 34.1, 34.2 (minor),
34.5 (minor), 34.6, 37.3, 39.3, 56.6, 80.2, 97.2 (minor), 97.4, 122.3,
122.6 (minor), 124.8, 126.3, 127.1 (minor), 128.2 (minor), 128.4
(minor), 128.6, 141.0, 142.0 (minor), 145.7, 152.2, 156.3 ppm; LRMS
(EI): m/z (%): 346 (52) [C18H1781BrO2]+, 344 (53) [C18H1779BrO2]+, 242
(95), 240 (99), 161 (100), 149 (32), 133 (40), 104 (58), 103 (56), 102
(33), 91 (80), 90 (31), 89 (34), 78 (37), 77 (60), 71 (38), 69 (59), 57
(63), 55 (49); HRMS (TOF): m/z calcd for C18H1879BrO2 [M+H]+,
C18H1881BrO2 [M+H]+: 345.0484, 347.0464; found: 345.0473;
347.0463.
Compound 30d[19]
Following the general procedure for the [PtCl4]-mediated genera-
tion of the o-QM/HDA reaction, indanyl acetate 23 (0.020 g,
0.056 mmol) reacted with cinnamate 29d (0.026 g, 0.112 mmol) for
18 h to give 30d as a pale yellow solid (0.010 g, 0.021 mmol, 38%).
Compound 26
Following the general procedure for the borohydride reduction/
acetylation and [PtCl4]-mediated generation of o-QM and HDA re-
action, the tetralone 22 (0.04 g, 0.11 mmol) was converted into the
chroman 26 as a white solid of a 3:1 mixture of inseparable diaste-
1
M.p. (EtOAc/hexanes) 113.7–116.08C; H NMR (300 MHz, CDCl3): d=
0.99 (t, J=7.1 Hz, 3H), 1.68–1.84 (m, 1H), 2.34–2.46 (m, 1H), 2.81
(apparent t, J=10.5 Hz, 1H), 2.85–3.05 (m. 2H), 3.59 (dt, J=10.5,
6.5 Hz, 1H), 3.81 (s, 3H), 3.83 (s, 3H), 3.95 (q, J=7.1 Hz, 2H), 5.48
(d, J=10.5 Hz, 1H), 6.28 (s, 1H), 7.05 (d, J=1.6 Hz, 1H), 7.12 (dd,
J=8.1, 1.6 Hz, 1H), 7.21 ppm (d, J=8.1 Hz, 1H); 13C NMR (75 MHz,
CDCl3): d=13.9, 14.4 (minor), 30.6 (minor), 33.2 (minor), 33.4, 33.9,
35.0, 43.1, 43.4, 50.1, 55.6 (minor), 55.8, 56.45, 56.54 (minor), 56.6,
60.4 (minor), 60.5, 74.1 (minor), 76.1, 96.8 (minor), 97.3, 99.3, 111.1
(minor), 112.1 (minor), 112.7, 113.4 (minor), 114.6, 115.1, 120.7,
126.7, 129.9 (minor), 145.2 (minor), 145.6, 151.7, 151.9, 153.5
1
reomers (0.014 g, 0.04 mmol, 35%). H NMR (400 MHz, CDCl3): d=
1.18–1.30 (m, 2H), 1.71–1.83 (m, 2H, minor), 1.94–2.01 (m, 1H),
2.04–2.12 (m, 1H, minor), 2.15–2.22 (m, 1H), 2.27–2.35 (m, 1H,
minor), 2.60–2.69 (m, 2H), 2.88–3.02 (m, 3H), 3.83 (s, 3H), 3.88 (s,
3H, minor), 5.19 (dd, J=2.3 Hz, 1H), 5.57 (d, J=3.8 Hz, 1H, minor),
6.39 (s, 1H), 6.48 (s, 1H, minor), 7.31–7.44 ppm (m, 5H); 13C NMR
(100 MHz, CDCl3): d=22.5 (minor), 22.7, 26.9 (minor), 28.7 (minor),
29.0, 29.6 (minor), 30.6, 34.0, 34.4 (minor), 37.4, 56.2, 75.9 (minor),
&
&
Chem. Asian J. 2015, 00, 0 – 0
12
ꢀ 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ÝÝ These are not the final page numbers!